Series B - MabSpace Biosciences
Investment Firm
Overview
MabSpace Biosciences is a biotech company focused on discovery & development of innovative antibody based therapeutics for cancer.
Announced Date
May 11, 2018
Funding Type
Series B
Highlights
Location
Asia
Social
Investor Lead
N/A
Participant Investors
1
| Investor Name |
|---|
 Lilly Asia Ventures |
Round Details and Background
MabSpace Biosciences raised $40000000 on 2018-05-11 in Series B
MabSpace Biosciences is a biotech company focused on discovery & development of innovative antibody based therapeutics for cancer.
Company Funding History
2
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| May 11, 2018 |  Series B - MabSpace Biosciences | 3 | - | 40.0M |
| Oct 29, 2015 | Series A - MabSpace Biosciences | 1 | - | 15.0M |
Recent Activity
There is no recent news or activity for this profile.